SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51153There's more than one parameter to measure. I'm stumbling in the dark tA.J. Mullen-11/5/2019
51152This post is where it will become obvious how bad an investor I am. I thought tatticus4paws-11/5/2019
51151The short presentation links to a phase 2 maintenance dialysis trial ( Provenzabiocqr-11/5/2019
51150<As I noted previously, if Plainview is correct, then there will be lawsuits.Miljenko Zuanic-11/5/2019
51149I too am long FGEN and agree that it is well set for a short attack. Plainview A.J. Mullen-11/5/2019
51148"Is it likely not still superior to EPO in ID and DD (and superior/non-infeArt Bechhoefer-11/4/2019
51147138 pages? Shouldn't take more than a few tables of numbers and graphs to ssemi_infinite -11/4/2019
51146I think FGEN, due to past communications that were vague enough to be poorly recatticus4paws-11/4/2019
51145fgen short attack is buying op simple. bgne had short attack abt fraudulent datlinhtu-11/4/2019
51144After reading portions of the Plainview report on FGEN, I have even more questioArt Bechhoefer-11/4/2019
51143The report is 138 pages on fgen. That is scary. It sure is difficult owning biCpi3663-11/4/2019
51142Thanks for posting. I recall discussion that MACE was inappropriate because patA.J. Mullen-11/4/2019
51141The Plainview comments look very suspicious to me, for several reasons: 1. A deArt Bechhoefer-11/4/2019
51140Reprogramming Bacteriophage Host Range through Structure-Guided Design of Chimernigel bates-11/4/2019
51139The short thesis for FGEN's roxadustat: Plainviewbmaz001-11/4/2019
51138Interesting new Alzheimer's drug approved in China... Novel Drug Treatment biocqr111/3/2019
51137Social connections first, science second: How biotech’s recipe for success has iBulbaMan-10/31/2019
51136Medicare open enrollment plan finder, part 2: 1) I spoke to medicare about thesoftware salesperson-10/29/2019
51135Actinium announced interim results that seemed good to me, finance.yahoo.com, yeA.J. Mullen-10/28/2019
51134New drug forces flu virus into ‘error catastrophe,’ overwhelming it with mutatiobiocqr-10/27/2019
51133PMN.TO looks like another underfunded Canadian biotech with fantastic potential tnsaf-10/27/2019
51132Late last year, Rudy Tanzi joined the SAB of the tiny, $45 million market cap, CBulbaMan-10/23/2019
51131Alzheimer’s: statnews.com - - aducanumab beingpatient.com - - Tanzi , 2018 ncsoftware salesperson210/22/2019
51130medicare open enrollment: I made a lot of laudatory remarks about medicare in msoftware salesperson-10/22/2019
51129Thanks. Progress (slow?). If any of these work....geeez.atticus4paws-10/15/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News